« December 2004 | Main | February 2005 »

Oxfam America

Oxfam is sending food and water to help thousands of people affected by the devastating tsunamis that struck coastal areas of several Asian countries.

Give here.

Or check out these organizations from The American Institute of Philanthropy list of top-rated charities here.

January 5, 2005 in environment | Permalink | Comments (0)

Shadow Cast Over Alternative Medicine Death From Hydrogen Peroxide Sends Shockwaves Throughout Medical Profession

When Katherine Bibeau's body arrived at the morgue, she was covered in large, purplish-black bruises, almost as if she had been beaten to death.

But this was no beating. Coroner Gary Watts attributed Bibeau's massive internal bleeding to the unconventional treatment she sought for her multiple sclerosis: an intravenous infusion of hydrogen peroxide - the same first-aid kit standby that's used to clean cuts and scrapes.

Watts concluded that the hydrogen peroxide administered by Dr. James Shortt produced bubbles in Bibeau's bloodstream that started her down a fatal spiral into multiple organ failure and cardiac arrest.

On the line of his report asking for "manner of death," Watts wrote one word: "Homicide."

More here.

January 5, 2005 in complementary and alternative medicine | Permalink | Comments (1)

The Swift Report: White House Exploring 'Rapture' Contingency Plans

The White House is reportedly exploring contingency plans in the event that President Bush and other prominent Christians are 'raptured.' But succession plans are complicated by Vice President Dick Cheney's poor health and the fact that Representative Tom DeLay, like President Bush, will be summoned to heaven along with millions of other Christians.

Rise here.

Move to Alaska quick, Uncle Ted may soon be President Ted.

January 5, 2005 in alaska, humor, politics | Permalink | Comments (0)

Serono Completes Patient Enrollment in Rebif(R) Versus Copaxone(R) Comparative Clinical Trial

Serono (virt-x: SEO and NYSE: SRA) announced today that patient enrollment has been completed in a multi-national Rebif(R) (interferon beta-1a) versus Copaxone(R) (glatiramer acetate) comparative clinical trial. This two-year trial is designed to compare the efficacy of the two therapies in patients with relapsing remitting multiple sclerosis (RRMS), who were previously untreated with disease modifying therapies.

More here.

January 5, 2005 in copaxone, rebif, research, worth following... | Permalink | Comments (0)